some color behind pancan strategic reevaluation After four years of operation, PanCAN underwent a strategic re-evaluation of Precision Promise in late 2023. It was a good time to evaluate the program to determine if there were opportunities to continue to innovate the study. While the study has been successful, we also wanted to see if there were ways to be more efficient.
The financial model for Precision Promise was dependent on a steady stream of new
investigational agents coming into the study. The last year has been a challenging
economic environment for pharma and biotech companies. So, we wanted to evaluate if a
collaboration or alliance with another organization could stabilize the financial model
by streamlining operations and efficiencies while still accomplishing the study
objectives. We are excited to announce that PanCAN made a strategic decision to
collaborate with GCAR (Global Coalition for Adaptive Research) and take advantage of the
strengths of both organizations to pursue the long-term sustainability of a new
pancreatic cancer clinical trial platform for patients.
The goals of the alliance are increased efficiency and scalability with GCAR sponsoring
the study and overseeing the operations, and PanCAN providing disease expertise and
relationships with the pancreatic cancer community. It brings together the strengths of
both organizations for patient benefit.
About Global Coalition for Adaptive Research
The Global Coalition for Adaptive Research (GCAR) unites physicians, clinical researchers, advocacy and philanthropic organizations, biotech/pharma, health authorities, and other key stakeholders in healthcare to expedite the discovery and development of treatments for patients with rare and deadly diseases. As Sponsor of innovative trials, including master protocols and adaptive platform trials, GCAR is dedicated to the advancement of science by modernizing clinical trials that support more efficient, less costly drug development. Adaptive platform trials deliver an unmatched accelerated time from discovery in the lab to implementation in the clinic resulting in better treatments and lives saved. To learn more about GCAR and its initiatives, visit gcaresearch.org.